<table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col></col>
<col></col>
<col></col>
<col></col>
<thead>
<tr>
<th colspan="4" stylecode="     Toprule         Lrule          Rrule     ">Table 1: Select Mean (±S.D.) Metformin Pharmacokinetic Parameters Following Single or Multiple Oral Doses of Metformin Hydrochloride Tablets</th>
</tr>
<tr>
<th align="center" stylecode="     Toprule         Lrule          Rrule     ">Subject Groups: Metformin Hydrochloride Tablets dosea<br/>(number of subjects)</th>
<th align="center" stylecode="     Toprule         Lrule          Rrule     ">C<sub>max</sub>
<sup>b</sup>
<br/>(µg/mL)</th>
<th align="center" stylecode="     Toprule         Lrule          Rrule     ">T<sub>max</sub>
<sup>c</sup>
<br/>(hrs)</th>
<th align="center" stylecode="     Toprule         Lrule          Rrule     ">Renal Clearance<br/>(mL/min)</th>
</tr>
</thead>
<tbody>
<tr>
<td stylecode="    Lrule          Rrule     " valign="top"> <content stylecode="bold">Healthy, nondiabetic adults: </content>
<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> </td>
<td align="center" stylecode="     Rrule     " valign="top"> </td>
<td align="center" stylecode="     Rrule     " valign="top"> </td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     " valign="top"> 500 mg single dose (24) <br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 1.03 (±0.33)<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 2.75 (±0.81)<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 600 (±132)<br/>
</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     " valign="top"> 850 mg single dose (74)<sup>d</sup>
<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 1.60 (±0.38)<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 2.64 (±0.82)<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 552 (±139)<br/>
</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     " valign="top"> 850 mg three times daily for 19 doses<sup>e</sup> (9)<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 2.01 (±0.42)<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 1.79 (±0.94)<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 642 (±173)<br/>
</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     " valign="top"> <content stylecode="bold">Adults with type 2 diabetes: </content>
<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> </td>
<td align="center" stylecode="     Rrule     " valign="top"> </td>
<td align="center" stylecode="     Rrule     " valign="top"> </td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     " valign="top"> 850 mg single dose (23) <br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 1.48 (±0.5)<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 3.32 (±1.08)<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 491 (±138)<br/>
</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     " valign="top"> 850 mg three times daily for 19 doses<sup>e</sup> (9)<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 1.90 (±0.62)<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 2.01 (±1.22)<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 550 (±160)<br/>
</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     " valign="top"> <content stylecode="bold">Elderly</content>
<sup>f </sup>, <content stylecode="bold">healthy nondiabetic adults: </content>
<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> </td>
<td align="center" stylecode="     Rrule     " valign="top"> </td>
<td align="center" stylecode="     Rrule     " valign="top"> </td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     " valign="top"> 850 mg single dose (12)<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 2.45 (±0.70)<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 2.71 (±1.05)<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 412 (±98)<br/>
</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     " valign="top"> <content stylecode="bold">Renal-impaired adults: </content>
<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> </td>
<td align="center" stylecode="     Rrule     " valign="top"> </td>
<td align="center" stylecode="     Rrule     " valign="top"> </td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     " valign="top"> <content stylecode="bold">850 mg single dose </content>
<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> </td>
<td align="center" stylecode="     Rrule     " valign="top"> </td>
<td align="center" stylecode="     Rrule     " valign="top"> </td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     " valign="top"> <content stylecode="bold">Mild</content> (CL<sub>cr</sub>
<sup>g</sup> 61-90 mL/min) (5) <br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 1.86 (±0.52)<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 3.20 (±0.45)<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 384 (±122)<br/>
</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     " valign="top"> <content stylecode="bold">Moderate</content> (CL<sub>cr</sub> 31-60 mL/ min) (4)<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 4.12 (±1.83)<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 3.75 (±0.50)<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 108 (±57)<br/>
</td>
</tr>
<tr>
<td stylecode="    Lrule          Rrule     " valign="top"> <content stylecode="bold">Severe</content> (CL<sub>cr</sub> 10-30 mL/min) (6) <br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 3.93 (±0.92)<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 4.01 (±1.10)<br/>
</td>
<td align="center" stylecode="     Rrule     " valign="top"> 130 (±90)<br/>
</td>
</tr>
<tr>
<td colspan="4" stylecode="    Lrule          Rrule     " valign="top"> <sup>a</sup> All doses given fasting except the first 18 doses of the multiple dose studies <br/>
<sup>b</sup> Peak plasma concentration <br/>
<sup>c </sup>Time to peak plasma concentration <br/>
<sup>d </sup>Combined results (average means) of five studies: mean age 32 years (range 23-59 years) <br/>
<sup>e</sup> Kinetic study done following dose 19, given fasting <br/>
<sup>f</sup> Elderly subjects, mean age 71 years (range 65-81 years) <br/>
<sup>g</sup> CL<sub>cr</sub> = creatinine clearance normalized to body surface area of 1.73 m<sup>2</sup>
<br/>
</td>
</tr>
</tbody>
</table>